D-dimer: Difference between revisions
Jump to navigation
Jump to search
imported>Robert Badgett No edit summary |
imported>Robert Badgett No edit summary |
||
Line 2: | Line 2: | ||
==Using D-dimer to determine duration of anticoagulation treatment== | ==Using D-dimer to determine duration of anticoagulation treatment== | ||
An abnormal D-dimer level at the end of treatment might signal the need for continued [[anticoagulation]] with [[warfarin]] among patients with [[embolism and thrombosis]] such as a first unprovoked [[pulmonary | An abnormal D-dimer level at the end of treatment might signal the need for continued [[anticoagulation]] with [[warfarin]] among patients with [[embolism and thrombosis]] such as a first unprovoked [[pulmonary embolism]]. If the D-dimer is abnormal, anticoaguation should be continued, if the D-dimer is normal, the duration of treatment is uncertain.<ref name="pmid17065639">{{cite journal |author=Palareti G, Cosmi B, Legnani C, ''et al'' |title=D-dimer testing to determine the duration of anticoagulation therapy |journal=N. Engl. J. Med. |volume=355 |issue=17 |pages=1780-9 |year=2006 |pmid=17065639 |doi=10.1056/NEJMoa054444}}</ref> In an observation study that collected the D-dimer before stopping anticoagulation, the D-dimer was not as predictive.<ref>Rodger MA, Kahn SR, Wells PS, Anderson DA, Chagnon I, Le Gal G, et al. [Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapy http://www.cmaj.ca/cgi/content/full/179/5/417]. CMAJ. 2008 Aug 26;179(5):417-426.</ref> | ||
==References== | ==References== | ||
<references/> | <references/> |
Revision as of 12:54, 30 January 2009
In medicine, D-dimer is a fibrin degradation product after coagulation.
Using D-dimer to determine duration of anticoagulation treatment
An abnormal D-dimer level at the end of treatment might signal the need for continued anticoagulation with warfarin among patients with embolism and thrombosis such as a first unprovoked pulmonary embolism. If the D-dimer is abnormal, anticoaguation should be continued, if the D-dimer is normal, the duration of treatment is uncertain.[1] In an observation study that collected the D-dimer before stopping anticoagulation, the D-dimer was not as predictive.[2]
References
- ↑ Palareti G, Cosmi B, Legnani C, et al (2006). "D-dimer testing to determine the duration of anticoagulation therapy". N. Engl. J. Med. 355 (17): 1780-9. DOI:10.1056/NEJMoa054444. PMID 17065639. Research Blogging.
- ↑ Rodger MA, Kahn SR, Wells PS, Anderson DA, Chagnon I, Le Gal G, et al. [Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapy http://www.cmaj.ca/cgi/content/full/179/5/417]. CMAJ. 2008 Aug 26;179(5):417-426.